National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global Hypertension and Heart Failure Drugs Market Size, Status and Forecast 2019-2025

Global Hypertension and Heart Failure Drugs Market Size, Status and Forecast 2019-2025

Goods_sn:wanghaile-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global Hypertension and Heart Failure Drugs Market Size, Status and Forecast 2019-2025

Hard Copy: 3900 USD
PDF Copy (single user): 3900 USD
Multi User License: 5850 USD
Enterprise wide License: 7800 USD
Pages: 90
Tables and Figures: 105
Published Date: Oct. 2019
Publisher: QYR Medical Care Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Summary

Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to control HTN in CHF.
In 2018, the global Hypertension and Heart Failure Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hypertension and Heart Failure Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hypertension and Heart Failure Drugs development in United States, Europe and China.

The key players covered in this study
    Menarini Group
    Johnson & Johnson
    Lupin
    Boehringer Ingelheim
    Novartis
    Merck & Co
    AstraZeneca
    Pfizer, Inc
    Sanofi SA
    Dr. Reddy's Laboratories
    Daiichi Sankyo Company Limited

Market segment by Type, the product can be split into
    Diuretics
    Beta Blockers
    Ace Inhibitors
    Alpha Blockers
    Others

Market segment by Application, split into
    Men
    Women

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Hypertension and Heart Failure Drugs status, future forecast, growth opportunity, key market and key players.
    To present the Hypertension and Heart Failure Drugs development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hypertension and Heart Failure Drugs are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type (2014-2025)
        1.4.2 Diuretics
        1.4.3 Beta Blockers
        1.4.4 Ace Inhibitors
        1.4.5 Alpha Blockers
        1.4.6 Others
    1.5 Market by Application
        1.5.1 Global Hypertension and Heart Failure Drugs Market Share by Application (2014-2025)
        1.5.2 Men
        1.5.3 Women
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Hypertension and Heart Failure Drugs Market Size
    2.2 Hypertension and Heart Failure Drugs Growth Trends by Regions
        2.2.1 Hypertension and Heart Failure Drugs Market Size by Regions (2014-2025)
        2.2.2 Hypertension and Heart Failure Drugs Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Hypertension and Heart Failure Drugs Market Size by Manufacturers
        3.1.1 Global Hypertension and Heart Failure Drugs Revenue by Manufacturers (2014-2019)
        3.1.2 Global Hypertension and Heart Failure Drugs Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Hypertension and Heart Failure Drugs Market Concentration Ratio (CR5 and HHI)
    3.2 Hypertension and Heart Failure Drugs Key Players Head office and Area Served
    3.3 Key Players Hypertension and Heart Failure Drugs Product/Solution/Service
    3.4 Date of Enter into Hypertension and Heart Failure Drugs Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Hypertension and Heart Failure Drugs Market Size by Type (2014-2019)
    4.2 Global Hypertension and Heart Failure Drugs Market Size by Application (2014-2019)

5 United States
    5.1 United States Hypertension and Heart Failure Drugs Market Size (2014-2019)
    5.2 Hypertension and Heart Failure Drugs Key Players in United States
    5.3 United States Hypertension and Heart Failure Drugs Market Size by Type
    5.4 United States Hypertension and Heart Failure Drugs Market Size by Application

6 Europe
    6.1 Europe Hypertension and Heart Failure Drugs Market Size (2014-2019)
    6.2 Hypertension and Heart Failure Drugs Key Players in Europe
    6.3 Europe Hypertension and Heart Failure Drugs Market Size by Type
    6.4 Europe Hypertension and Heart Failure Drugs Market Size by Application

7 China
    7.1 China Hypertension and Heart Failure Drugs Market Size (2014-2019)
    7.2 Hypertension and Heart Failure Drugs Key Players in China
    7.3 China Hypertension and Heart Failure Drugs Market Size by Type
    7.4 China Hypertension and Heart Failure Drugs Market Size by Application

8 Japan
    8.1 Japan Hypertension and Heart Failure Drugs Market Size (2014-2019)
    8.2 Hypertension and Heart Failure Drugs Key Players in Japan
    8.3 Japan Hypertension and Heart Failure Drugs Market Size by Type
    8.4 Japan Hypertension and Heart Failure Drugs Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Hypertension and Heart Failure Drugs Market Size (2014-2019)
    9.2 Hypertension and Heart Failure Drugs Key Players in Southeast Asia
    9.3 Southeast Asia Hypertension and Heart Failure Drugs Market Size by Type
    9.4 Southeast Asia Hypertension and Heart Failure Drugs Market Size by Application

10 India
    10.1 India Hypertension and Heart Failure Drugs Market Size (2014-2019)
    10.2 Hypertension and Heart Failure Drugs Key Players in India
    10.3 India Hypertension and Heart Failure Drugs Market Size by Type
    10.4 India Hypertension and Heart Failure Drugs Market Size by Application

11 Central & South America
    11.1 Central & South America Hypertension and Heart Failure Drugs Market Size (2014-2019)
    11.2 Hypertension and Heart Failure Drugs Key Players in Central & South America
    11.3 Central & South America Hypertension and Heart Failure Drugs Market Size by Type
    11.4 Central & South America Hypertension and Heart Failure Drugs Market Size by Application

12 International Players Profiles
    12.1 Menarini Group
        12.1.1 Menarini Group Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Hypertension and Heart Failure Drugs Introduction
        12.1.4 Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.1.5 Menarini Group Recent Development
    12.2 Johnson & Johnson
        12.2.1 Johnson & Johnson Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Hypertension and Heart Failure Drugs Introduction
        12.2.4 Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.2.5 Johnson & Johnson Recent Development
    12.3 Lupin
        12.3.1 Lupin Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Hypertension and Heart Failure Drugs Introduction
        12.3.4 Lupin Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.3.5 Lupin Recent Development
    12.4 Boehringer Ingelheim
        12.4.1 Boehringer Ingelheim Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Hypertension and Heart Failure Drugs Introduction
        12.4.4 Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.4.5 Boehringer Ingelheim Recent Development
    12.5 Novartis
        12.5.1 Novartis Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Hypertension and Heart Failure Drugs Introduction
        12.5.4 Novartis Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.5.5 Novartis Recent Development
    12.6 Merck & Co
        12.6.1 Merck & Co Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Hypertension and Heart Failure Drugs Introduction
        12.6.4 Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.6.5 Merck & Co Recent Development
    12.7 AstraZeneca
        12.7.1 AstraZeneca Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Hypertension and Heart Failure Drugs Introduction
        12.7.4 AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.7.5 AstraZeneca Recent Development
    12.8 Pfizer, Inc
        12.8.1 Pfizer, Inc Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Hypertension and Heart Failure Drugs Introduction
        12.8.4 Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.8.5 Pfizer, Inc Recent Development
    12.9 Sanofi SA
        12.9.1 Sanofi SA Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Hypertension and Heart Failure Drugs Introduction
        12.9.4 Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.9.5 Sanofi SA Recent Development
    12.10 Dr. Reddy's Laboratories
        12.10.1 Dr. Reddy's Laboratories Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Hypertension and Heart Failure Drugs Introduction
        12.10.4 Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2014-2019)
        12.10.5 Dr. Reddy's Laboratories Recent Development
    12.11 Daiichi Sankyo Company Limited

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details


List of Tables and Figures

    Table Hypertension and Heart Failure Drugs Key Market Segments
    Table Key Players Hypertension and Heart Failure Drugs Covered
    Table Global Hypertension and Heart Failure Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Hypertension and Heart Failure Drugs Market Size Market Share by Type 2014-2025
    Figure Diuretics Figures
    Table Key Players of Diuretics
    Figure Beta Blockers Figures
    Table Key Players of Beta Blockers
    Figure Ace Inhibitors Figures
    Table Key Players of Ace Inhibitors
    Figure Alpha Blockers Figures
    Table Key Players of Alpha Blockers
    Figure Others Figures
    Table Key Players of Others
    Table Global Hypertension and Heart Failure Drugs Market Size Growth by Application 2014-2025 (Million US$)
    Figure Men Case Studies
    Figure Women Case Studies
    Figure Hypertension and Heart Failure Drugs Report Years Considered
    Table Global Hypertension and Heart Failure Drugs Market Size 2014-2025 (Million US$)
    Figure Global Hypertension and Heart Failure Drugs Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Hypertension and Heart Failure Drugs Market Size by Regions 2014-2025 (Million US$)
    Table Global Hypertension and Heart Failure Drugs Market Size by Regions 2014-2019 (Million US$)
    Table Global Hypertension and Heart Failure Drugs Market Share by Regions 2014-2019
    Figure Global Hypertension and Heart Failure Drugs Market Share by Regions 2014-2019
    Figure Global Hypertension and Heart Failure Drugs Market Share by Regions 2019
    Table Market Top Trends
    Table Global Hypertension and Heart Failure Drugs Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Hypertension and Heart Failure Drugs Market Share by Manufacturers (2014-2019)
    Figure Global Hypertension and Heart Failure Drugs Market Share by Manufacturers in 2019
    Table Global Hypertension and Heart Failure Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Hypertension and Heart Failure Drugs Product/Solution/Service
    Table Date of Enter into Hypertension and Heart Failure Drugs Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table Global Hypertension and Heart Failure Drugs Market Size Share by Type (2014-2019)
    Figure Global Hypertension and Heart Failure Drugs Market Size Market Share by Type (2014-2019)
    Table Global Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table Global Hypertension and Heart Failure Drugs Market Size Share by Application (2014-2019)
    Figure Global Hypertension and Heart Failure Drugs Market Size Market Share by Application (2014-2019)
    Figure Global Hypertension and Heart Failure Drugs Revenue Market Share by Application in 2018
    Figure United States Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table United States Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
    Table United States Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table United States Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table United States Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table United States Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table United States Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Figure Europe Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table Europe Key Players Hypertension and Heart Failure Drugs Revenue (2014-2019) (Million US$)
    Table Europe Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table Europe Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table Europe Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table Europe Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table Europe Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Figure China Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table China Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
    Table China Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table China Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table China Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table China Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table China Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Figure Japan Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table Japan Key Players Hypertension and Heart Failure Drugs Revenue (2014-2019) (Million US$)
    Table Japan Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table Japan Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table Japan Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table Japan Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table Japan Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Figure Southeast Asia Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table Southeast Asia Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table Southeast Asia Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Figure India Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table India Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
    Table India Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table India Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table India Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table India Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table India Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Figure Central & South America Hypertension and Heart Failure Drugs Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Hypertension and Heart Failure Drugs Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Hypertension and Heart Failure Drugs Market Share (2018-2019)
    Table Central & South America Hypertension and Heart Failure Drugs Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Hypertension and Heart Failure Drugs Market Share by Type (2014-2019)
    Table Central & South America Hypertension and Heart Failure Drugs Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Hypertension and Heart Failure Drugs Market Share by Application (2014-2019)
    Table Menarini Group Company Details
    Table Menarini Group Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Menarini Group Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Menarini Group Recent Development
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Johnson & Johnson Recent Development
    Table Lupin Company Details
    Table Lupin Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Lupin Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Lupin Recent Development
    Table Boehringer Ingelheim Company Details
    Table Boehringer Ingelheim Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Boehringer Ingelheim Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Boehringer Ingelheim Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Novartis Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Novartis Recent Development
    Table Merck & Co Company Details
    Table Merck & Co Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Merck & Co Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Merck & Co Recent Development
    Table AstraZeneca Company Details
    Table AstraZeneca Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure AstraZeneca Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table AstraZeneca Recent Development
    Table Pfizer, Inc Company Details
    Table Pfizer, Inc Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Pfizer, Inc Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Pfizer, Inc Recent Development
    Table Sanofi SA Company Details
    Table Sanofi SA Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Sanofi SA Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Sanofi SA Recent Development
    Table Dr. Reddy's Laboratories Company Details
    Table Dr. Reddy's Laboratories Revenue in Hypertension and Heart Failure Drugs Business (2014-2019) (Million US$)
    Figure Dr. Reddy's Laboratories Revenue Growth Rate in Hypertension and Heart Failure Drugs Business (2014-2019)
    Table Dr. Reddy's Laboratories Recent Development
    Table Daiichi Sankyo Company Limited Company Details
    Table Global Hypertension and Heart Failure Drugs Market Size by Regions (Million US$) 2019-2025
    Figure Global Hypertension and Heart Failure Drugs Market Size Share by Regions (2019-2025)
    Figure Global Hypertension and Heart Failure Drugs Market Size Share by Regions in 2025
    Figure United States Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure China Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure India Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Hypertension and Heart Failure Drugs Market Size Forecast (2019-2025)(Million USD)
    Table Global Hypertension and Heart Failure Drugs Market Size by Product (2019-2025) (Million US$)
    Figure Global Hypertension and Heart Failure Drugs Market Size by Product (2019-2025)
    Figure Global Hypertension and Heart Failure Drugs Market Size by Product in 2025
    Table Global Hypertension and Heart Failure Drugs Market Size by Application (2019-2025) (Million US$)
    Figure Global Hypertension and Heart Failure Drugs Market Size by Application (2019-2025)
    Figure Global Hypertension and Heart Failure Drugs Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.